128 results
POS AM
SPRC
SciSparc Ltd
17 Jun 24
Prospectus update (post-effective amendment)
4:05pm
on the global macro-economic environment, can impact AutoMax’s business, operating results, and financial condition. Furthermore, as the majority of AutoMax’s … . Substantially all its cost of purchases is either in U.S. dollars or Euros while the majority of its revenues and AutoMax’s management, marketing, sales
POS AM
SPRC
SciSparc Ltd
2 May 24
Prospectus update (post-effective amendment)
5:17pm
, operating results, and financial condition. Furthermore, as the majority of AutoMax’s customers rely on credit financing to purchase vehicles … the majority of its revenues and AutoMax’s management, marketing, sales and research and development costs are in NIS. AutoMax is therefore exposed
425
SPRC
SciSparc Ltd
2 May 24
Business combination disclosure
4:46pm
, rejected by a majority of votes the amendment to the Basic Law: the Judiciary (Reduction of the Reason for Reasonableness).
F-18
Automax Motors Ltd … will be appointed by the marketer and one by the subsidiary. The Founder’s Agreement also stipulates that certain decisions will require a 100% majority
6-K
EX-99.1
SPRC
SciSparc Ltd
2 May 24
Consolidated Financial Statements as for Consolidated Financial Statements as for To the shareholders of
4:02pm
Court, in its session as the High Court of Justice, rejected by a majority of votes the amendment to the Basic Law: the Judiciary (Reduction … decisions will require a 100% majority of the directors, including a change in the joint company’s incorporation documents, including a change
6-K
EX-99.2
SPRC
SciSparc Ltd
2 May 24
Consolidated Financial Statements as for Consolidated Financial Statements as for To the shareholders of
4:02pm
the majority of the board of directors of the combined company following the consummation of the Acquisition; and
SciSparc’s senior management
20-F/A
4ozaouve162r08ew 0e
2 May 24
Annual report (foreign) (amended)
9:18am
425
2u4e4dm4a jjudurx
12 Apr 24
Business combination disclosure
9:23am
6-K
EX-99.1
w3fyqg4go
11 Apr 24
Agreement and Plan of Merger
4:05pm
S-8
zzm8b cc07fk
1 Apr 24
Registration of securities for employees
5:11pm
F-1
f7l9l
27 Feb 24
Registration statement (foreign)
4:15pm
F-1
EX-10.7
28bybp ifap29j
27 Feb 24
Registration statement (foreign)
4:15pm
6-K
EX-4.1
cmrwwh8dw44s
25 Jan 24
SciSparc Ltd. Announces $20 Million Standby Equity Purchase Agreement
9:05am
6-K
EX-10.1
x9ef2az ccvahm0deb
25 Jan 24
SciSparc Ltd. Announces $20 Million Standby Equity Purchase Agreement
9:05am
6-K
5n2xyk 0jim7
28 Nov 23
Report of Foreign Private Issuer
4:01pm
6-K
EX-4.1
5xg6p
28 Nov 23
Report of Foreign Private Issuer
4:01pm
6-K
EX-99.1
ooe86e415lai
27 Nov 23
SciSparc Announces Positive Results for MitoCareX Bio with its Drug Discovery Platform
4:00pm
F-3/A
hv9ilpbjjo
20 Nov 23
Shelf registration (foreign) (amended)
4:22pm